Shakespeare & Company Announces New Board Members
 |
LENOX, Mass. — Shakespeare & Company announces the addition of three new board members to the company's Board of Trustees.
The new members joining the board are Nancy Edman Feldman, Erick Lucera and Andrew D. Rothstein.
"I'm thrilled with the steady increase in board membership over the last few years, and the diverse group of talented people we’ve added this year," said Board Chair Kenneth Werner. "Their prior experience on other nonprofit boards and variety of work experiences should add a lot to our Board of Trustees."
The 2018 Shakespeare & Company Board of Trustees includes: Kenneth E. Werner (Chair), Jeffrey B. Konowitch (Vice Chair), Barry R. Shapiro (Vice Chair), Michael Helfer (Treasurer), Michael A. Miller (Clerk), Jerome Berko, Sandra Bourgeois, George Camarda, Kevin G. Coleman, Gerald Friedman, M.D., Ph.D., Michael Fuchs, Phoebe L. Giddon, Dr. Beverly Hyman, Jennie M. Jadow, Dennis Krausnick, Barri Marks, Maureen O'Hanlon, Helga S. Orthofer, Tina Packer, Claudia Perles, Scott Rubinow, William M. Ryan, David A. Smith, Robert B. Strassler, John Douglas Thompson, and Suzanne Werner.
"Each of these fine people bring a unique expertise to our Board," said Artistic Director Allyn Burrows. "We are fortunate to have them take a keen interest in what we put forward with our work. It’s a pleasure to welcome them."
The newly appointed trustees each began their term as board member of Shakespeare & Company this August.
Edman Feldman has interior design expertise in developing new environments customized for her clients, focusing on their personal lifestyle requirements, while creating beautifully high-styled surroundings; introducing as many sustainable and energy-saving products as possible. She has over 50+ years of membership in ASID, the American Society of Interior Designers as well as membership in IFDA, the International Furnishings and Design Association.
Lucera joined Valeritas as chief financial officer in August 2016. Prior to joining Valeritas, Lucera served as chief financial officer, treasurer and secretary of Viventia Bio. From 2012 to 2015, he was vice president, corporate development at Aratana Therapeutics, a veterinary biopharmaceutical company. While at Aratana, he helped grow the company’s product pipeline through a series of acquisitions and in licensing transactions financed through five public and private offerings of nearly $250 million.
Rothstein is a trusts and estates lawyer at Goulston & Storrs PC in Boston. His practice focuses on tax-efficient wealth transfer planning. In his work, he provides clients with a full understanding of legal and tax rules associated with accumulating, managing, and transferring wealth, helping them to develop legal structures and tax strategies to transfer and preserve wealth. He also serves as a trustee for charitable and non-charitable trusts, owning marketable and non-marketable assets.
